Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6407 ARTÍCULOS , VIENDO DEL 4231 AL 4245

[Long-term effects of deep brain stimulation for movement disorders: a literature-based analysis]

Eberhardt O, Reithmeier T, Topka H.

Nervenarzt. 2014 Dec;85(12):1551-60. doi: 10.1007/s00115-014-4210-8.

Disruption of SOX6 is associated with a rapid-onset dopa-responsive movement disorder, delayed development, and dysmorphic features

Ebrahimi-Fakhari D, Maas B, Haneke C, Niehues T, Hinderhofer K, Assmann BE, Runz H.

Pediatr Neurol. 2015 Jan;52(1):115-8. doi: 10.1016/j.pediatrneurol.2014.08.021. Epub 2014 Sep 17.

Outcomes, management, and potential mechanisms of interleaving deep brain stimulation settings

Miocinovic S, Khemani P, Whiddon R, Zeilman P, Martinez-Ramirez D, Okun MS, Chitnis S.

Parkinsonism Relat Disord. 2014 Dec;20(12):1434-7. doi: 10.1016/j.parkreldis.2014.10.011. Epub 2014 Oct 22.

Efficacy and safety of paliperidone extended release in adolescents with schizophrenia: a randomized, double-blind study

Savitz AJ, Lane R, Nuamah I, Gopal S, Hough D.

J Am Acad Child Adolesc Psychiatry. 2015 Feb;54(2):126-137.e1. doi: 10.1016/j.jaac.2014.11.009. Epub 2014 Nov 25.

Movement disorders in childhood

Cardoso F.

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S13-6. doi: 10.1016/S1353-8020(13)70006-3.

[Deep brain stimulation for hyperkinetic movement disorders]

Reich MM, Volkmann J.

Nervenarzt. 2014 Feb;85(2):147-55. doi: 10.1007/s00115-013-3877-6.

Cognitive impairment in "Other" movement disorders: hidden defects and valuable clues

Walterfang M, van de Warrenburg BP.

Mov Disord. 2014 Apr 15;29(5):694-703. doi: 10.1002/mds.25849.

Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders [RETIRED]: report of the Guideline Development Subcommittee of the American Academy of Neurology

Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, Gloss D.

Neurology. 2014 Apr 29;82(17):1556-63. doi: 10.1212/WNL.0000000000000363.

Dystonia and tremor secondary to thalamic infarction successfully treated with thalamotomy of the ventralis intermedius nucleus

Álvarez M, Quintanal N, Díaz A, Prince J, García I, Carballo M, Rodríguez R, Maragoto C, Pedroso I, Macías R.

Mov Disord. 2014 Aug;29(9):1188-90. doi: 10.1002/mds.25889. Epub 2014 May 17.

Involuntary movements due to vitamin B12 deficiency

de Souza A, Moloi MW.

Neurol Res. 2014 Dec;36(12):1121-8. doi: 10.1179/1743132814Y.0000000396. Epub 2014 May 22.

Psychogenic Movement Disorders: Gait Is a Give-Away!

Balint B, van Winsen LML, Bhatia KP, Bloem BR.

Mov Disord Clin Pract. 2014 May 26;1(2):110-111. doi: 10.1002/mdc3.12031. eCollection 2014 Jun.

Modulation of mind: therapeutic neuromodulation for cognitive disability

Zibly Z, Shaw A, Harnof S, Sharma M, Graves C, Deogaonkar M, Rezai A.

J Clin Neurosci. 2014 Sep;21(9):1473-7. doi: 10.1016/j.jocn.2013.11.040. Epub 2014 Jun 2.

Undulating tongue in Wilson's disease

Nagappa M, Sinha S, Saini J, Bindu P, Taly A.

Ann Indian Acad Neurol. 2014 Apr;17(2):225-6. doi: 10.4103/0972-2327.132646.

Parkinson's disease: chameleons and mimics

Ali K, Morris HR.

Pract Neurol. 2015 Feb;15(1):14-25. doi: 10.1136/practneurol-2014-000849. Epub 2014 Sep 24.

[Movement disorders is psychiatric diseases]

Hidasi Z, Salacz P, Csibri E.

Neuropsychopharmacol Hung. 2014 Dec;16(4):205-11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias